AMC [AMC ENTERTAINMENT] 8-K: Item 5.02 Departure of Directors or Certain Officers;
[Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.]
GSI [GENERAL STEEL] 8-K: (Original Filing)
[General Steel Announces Change in Management Team BEIJING – February 4, 2016 About General Steel Holdings, Inc. General Steel Holdings, Inc. is headquartered in Beijing, China, and trades iron ore and steel products. To be added to the General Steel email list to receive Company news, or to request a hard copy of the Company’s Annual Report on Form 10-K,] []
GSI [GENERAL STEEL] 8-K: General Steel Announces Change in Management Team BEIJING
[General Steel Announces Change in Management Team BEIJING – February 4, 2016 About General Steel Holdings, Inc. General Steel Holdings, Inc. is headquartered in Beijing, China, and trades iron ore and steel products. To be added to the General Steel email list to receive Company news, or to request a hard copy of the Company’s Annual Report on Form 10-K,] []
CBAK [CHINA BAK BATTERY] 8-K: FORM 8-K CURRENT REPORT Date of Report (Date
[FORM 8-K CURRENT REPORT Date of Report (Date of Earliest Event Reported): CHINA BAK BATTERY, INC. Nevada 001-32898 86-0442833 (State or other jurisdiction (Commission File No.) (IRS Employer of incorporation) Identification No.) BAK Industrial Park, Meigui Street 86-411-39185985 Not applicable (Former name or former address, if changed since last report) ITEM 5.02. DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF]
BSPM [Biostar Pharmaceuticals] 8-K: (Original Filing)
[ARTICLES OF AMENDMENT TO THE ARTICLES OF INCORPORATION OF BIOSTAR PHARMACEUTICALS, INC. This is to certify that: FIRST SECOND THIRD FOURTH IN WITNESS WHEREOF Biostar Pharmaceuticals, Inc. Ronghua Wang Shuang Gong EX-3.1 2 ex3-1.htm EX-3.1] [Biostar Pharmaceuticals to Effect Reverse Stock Split XIANYANG, China, February 5, 2016 -- Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) (“Biostar” or “the Company”), a PRC-based developer, manufacturer and marketer of pharmaceutical and health supplement products in China, today announced that its Board of Directors unanimously approved a reverse split of its common stock at a ratio of 1-for-7, with anticipated trading] [FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): February 4, 2016 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue, Xianyang City, Shaanxi Province, People’s Republic of China 712046 86-029-33686638 N/A (Former name or former address, if changed since last report) ¨ ¨ ¨]
BSPM [Biostar Pharmaceuticals] 8-K: ARTICLES OF AMENDMENT TO THE ARTICLES OF INCORPORATION
[ARTICLES OF AMENDMENT TO THE ARTICLES OF INCORPORATION OF BIOSTAR PHARMACEUTICALS, INC. This is to certify that: FIRST SECOND THIRD FOURTH IN WITNESS WHEREOF Biostar Pharmaceuticals, Inc. Ronghua Wang Shuang Gong EX-3.1 2 ex3-1.htm EX-3.1] [Biostar Pharmaceuticals to Effect Reverse Stock Split XIANYANG, China, February 5, 2016 -- Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) (“Biostar” or “the Company”), a PRC-based developer, manufacturer and marketer of pharmaceutical and health supplement products in China, today announced that its Board of Directors unanimously approved a reverse split of its common stock at a ratio of 1-for-7, with anticipated trading] [FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): February 4, 2016 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue, Xianyang City, Shaanxi Province, People’s Republic of China 712046 86-029-33686638 N/A (Former name or former address, if changed since last report) ¨ ¨ ¨]
SYUT [Synutra International] 8-K: Synutra Special Committee Engages Independent Financial Advisor and
[Synutra Special Committee Engages Independent Financial Advisor and Legal Counsel in connection with “Going Private” Proposal QINGDAO, China and ROCKVILLE, Md., February 5, 2016 — Synutra International, Inc. (Nasdaq: SYUT) (“Synutra” or the “Company”), which owns subsidiaries in China that produce, distribute and sell nutritional products for infants, children and adults, today announced that the special committee of its board] []
SYUT [Synutra International] 8-K: (Original Filing)
[Synutra Reports Third Quarter Fiscal 2016 Financial Results ~Net Sales of $109 million ~Nutritional Food sales of $96 million Qingdao, China and Rockville, Md. – February 5, 2016 – Synutra International, Inc. (Nasdaq: SYUT), (“Synutra” or the “Company”), which owns subsidiaries in China that produce, distribute and sell nutritional products for infants, children and adults, today announced financial results for] []
HGSH [CHINA HGS REAL ESTATE] 8-K: (Original Filing)
[China HGS Reports First Quarter of Fiscal Year 2016 Results HANZHONG, CHINA February 5, 2016 Highlights for the Quarter l Total revenues for the first quarter of fiscal 2016 were approximately $5.9 million, a decrease of 44.6% from approximately $10.6 million in the same quarter of fiscal 2015. Total revenues recognized from percentage of completion method were approximately $2.7 million,] []
SYUT [Synutra International] 8-K: Synutra Reports Third Quarter Fiscal 2016 Financial Results
[Synutra Reports Third Quarter Fiscal 2016 Financial Results ~Net Sales of $109 million ~Nutritional Food sales of $96 million Qingdao, China and Rockville, Md. – February 5, 2016 – Synutra International, Inc. (Nasdaq: SYUT), (“Synutra” or the “Company”), which owns subsidiaries in China that produce, distribute and sell nutritional products for infants, children and adults, today announced financial results for] []
